The FDA is getting AI-aggressive about speeding up device reviews. Its plan is to unleash generative AI on tedious and repetitive tasks.

Deerfield Management released details on its latest Healthcare Innovations Fund program, promising to finance “promising therapeutics” and “elevating emerging technologies," including artificial intelligence. 

The agency said all of its centers will be fully integrated by June 30, following the success of an early pilot where generative AI supported scientific reviews. 

In a lawsuit, plaintiffs allege the company changed course from a long-standing policy of denying medical claims, hiding from investors its impact on profits. The insurer denies any wrongdoing and vowed to defend itself in court. 

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.

Integrating AI-based delegation tools into breast cancer screening settings could result in significant cost savings for organizations.

Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks. 

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

As time goes on, the gaps between the healthiest states and the least healthy states are only getting wider and wider. "Our findings highlight the urgent need for targeted strategies to reduce state-based inequities in cardiometabolic risk factors,” researchers wrote. 

Using one of the most powerful MRI scanners to date, researchers believe they have identified subtle neural changes in the brain that precede Parkinson’s disease.